Humoral immunity

DIAGNOSTIC_TEST2 trials

Sponsors

Zhongnan Hospital, Maria Goossens

Conditions

COVID-19ImmunotoxicitySARS CoV 2 InfectionSARS-CoV-2Safety

Unknown Phase

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

Zhongnan HospitalImmunotoxicity, Safety, SARS-CoV-2

Start: 2022-08-13End: 2023-03-01Target: 1000Updated: 2022-10-12

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations

Active, not recruitingNCT05667597

Maria GoossensCOVID-19, SARS CoV 2 Infection

Start: 2023-01-23End: 2026-12-31Updated: 2025-06-06